You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
創新醫療(002173.SZ)擬回購5000萬元-1億元股份 回購價不超9.5元/股
格隆匯 01-19 16:51

格隆匯1月19日丨創新醫療(002173.SZ)公佈,鑑於公司股票近期持續下跌,公司2021年1月11日股票收盤價(5.22元/股)低於最近一期每股淨資產(2020年第三季度每股淨資產為5.32元),且公司股票在連續二十個交易日內(2020年12月15日-2021年1月11日)收盤價跌幅累計已達到30%。基於對公司未來發展前景的堅定信心及對公司價值的判斷,為增強投資者信心,助力公司長遠發展,在綜合考慮業務發展前景、經營情況、財務狀況、未來盈利能力以及近期公司股票在二級市場表現的基礎上,依據中國證監會和深交所的相關規定,公司決定以自有資金通過集中競價的方式回購公司股份,用於維護公司價值及股東權益所必需。

此次回購股份的資金總額不低於人民幣5000萬元(含)且不超過人民幣1億元(含),公司用於此次擬回購的資金來源為自有資金。此次回購以公司2020年12月31日總股本4.55億股為基礎,在回購股份價格不超過9.5元/股的條件下,按照回購金額上限測算,預計可回購股份數量約為1052.6314股,約佔公司已發行總股本的2.31%;按照回購金額下限測算,預計可回購股份數量約為526.3157股,約佔公司已發行總股本的1.16%。具體回購的數量以回購期屆滿時實際回購的股份數量為準。回購股份的實施期限自公司董事會審議通過此次回購方案之日起3個月內。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account